Researchers recently developed two novel compounds that target the same subtype of serotonin receptors as LSD and psilocybin but do not produce hallucinations. Like psychedelic substances, these novel ...

Psilocybin — the main psychedelic compound in magic mushrooms — is the most famous and best-studied psychedelic substance. But beyond psilocybin, there are many other psychedelic compounds, some ...

Researchers have designed compounds that hit the same key receptor that LSD activates without causing hallucinations, according to an article (“Bespoke library docking for 5-HT 2A receptor agonists ...

New treatments for mental health and behavioral disorders are desperately needed. Rates of depression, anxiety, PTSD, and substance use disorders soared during the pandemic, and traditional ...

Classical psychedelics act on a surprisingly broad range of brain receptors, not just the serotonin receptor long associated with their hallucinogenic effects, according to new research published in ...

Psychedelics biotech BetterLife Pharma Inc. BETRF is fast-tracking its U.S. patent application covering the composition of matter, treatment uses and a novel production method of non-hallucinogenic ...

Patients in the MM-120 clinical trial open the door to a nondescript Lauderhill medical facility off Oakland Park Boulevard and find themselves staring at a large seed-of-life symbol on the wall, ...

Scientists Discover Multiple Pathways of the Main Receptor Activated by Psychedelics Scientists have designed compounds that hit the same key receptor that LSD activates without causing hallucinations ...

Psychedelics belong to a group of compounds called psychoplastogens, which can promote neuronal growth and restore atrophied connections in the brain. This ability makes the molecules promising as ...